NaPBA

DRUG2 trials

Sponsors

Amgen

Conditions

Urea Cycle DisorderUrea Cycle Disorders

Phase 2

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

CompletedNCT00947544

AmgenUrea Cycle Disorders

Start: 2010-03-31End: 2011-08-31Updated: 2024-07-11

Phase 4

Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)

CompletedNCT03335488

AmgenUrea Cycle Disorder

Start: 2018-02-20End: 2022-12-20Updated: 2024-07-01

Related Papers

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.

2013-01-0365 citations